This disclosure relates generally to density-based fluid separation and, in particular, to tube and multiple floats systems for the separation and axial expansion of constituent suspension components layered by centrifugation.
Suspensions often include materials of interest that are difficult to detect, extract and isolate for analysis. For instance, whole blood is a suspension of materials in a fluid. The materials include billions of red and white blood cells and platelets in a proteinaceous fluid called plasma. Whole blood is routinely examined for the presence of abnormal organisms or cells, such as ova, fetal cells, endothelial cells, parasites, bacteria, and inflammatory cells, and viruses, including HIV, cytomegalovirus, hepatitis C virus, and Epstein-Barr virus. Currently, practitioners, researchers, and those working with blood samples try to separate, isolate, and extract certain components of a peripheral blood sample for examination. Typical techniques used to analyze a blood sample include the steps of smearing a film of blood on a slide and staining the film in a way that enables certain components to be examined by bright field microscopy.
On the other hand, materials of interest composed of particles that occur in very low numbers are especially difficult if not impossible to detect and analyze using many existing techniques. Consider, for instance, circulating tumor cells (“CTCs”), which are cancer cells that have detached from a tumor, circulate in the bloodstream, and may be regarded as seeds for subsequent growth of additional tumors (i.e., metastasis) in different tissues. The ability to accurately detect and analyze CTCs is of particular interest to oncologists and cancer researchers, but CTCs occur in very low numbers in peripheral whole blood samples. For instance, a 7.5 ml sample of peripheral whole blood that contains as few as 5 CTCs is considered clinically relevant in the diagnosis and treatment of a cancer patient. However, detecting even 1 CTC in a 7.5 ml blood sample is equivalent to detecting 1 CTC in a background of about 50 billion red and white blood cells. Using existing techniques to find, isolate and extract as few as 3 CTCs of a whole blood sample is extremely time consuming, costly and may be impossible to accomplish.
As a result, practitioners, researchers, and those working with suspensions continue to seek systems and methods to more efficiently and accurately detect, isolate and extract target materials of a suspension.
This disclosure is directed to systems and methods for analyzing multiple target analytes of a suspension. The system includes a tube and multiple floats. Each float has a different density and no two floats have the same density, such that each float traps a different target analyte within the suspension. In one aspect, the floats include complementary mating features to allow for mating or trapping of material between consecutive floats. In another aspect, the floats do not include the complementary mating features. One of the target analytes may be used to assess quality control or may aid in a subsequent analysis or diagnosis.
The detailed description is organized into two subsections: 1) a general description of tube and multiple floats systems is provided in a first subsection; and 2) methods for using tube and multiple float systems to analyze target analytes of a suspension.
It should be understood that “fraction” may refer to a visually- or physically-delineated component of a suspension after undergoing density-based separation, such as by centrifugation. A visual delineation is one in which the actual separation can be seen by the naked eye, whereas a physical separation is one in which components are separated, though the delineation may not be seen by the naked eye. A fraction, for example, may be small in number such that after centrifugation the fraction is physically separated from other fractions by density, though the separation and delineation is not seen by the naked eye.
General Description of Tube and Multiple Floats Systems
A float may also have a concave end (top or bottom) which is complementary in nature to a protruding end cap (top or bottom) of another float to promote interaction of the two floats, whether by mating or trapping a target analyte or suspension material between the floats.
The concavity may be teardrop-shaped, conical, spherical, circular, tetrahedral, or any other appropriate shape. Alternatively, the outer diameter of the main body 202 may be sized to be equal to or greater than the inner diameter of the tube 102. Alternatively, the complementary end caps (i.e. the respective caps of respective floats configured to mate together) may be planar or substantially planar. The corners connecting the planar or substantially planar facets of the end caps to the sides of the end caps may be straight, curved, angled, or chamfered. Embodiments include other types of geometric shapes for float end caps.
In other embodiments, the main body of the float 104 can include a variety of different support members for separating target materials, supporting the tube wall, or directing the suspension fluid around the float during centrifugation.
Each of the multiple floats can be composed of a metal or metalloid; compressible materials, such as compressible polymers; organic or inorganic materials; plastic materials; and combinations thereof.
The support members may be included during the forming or machining processes or added after the forming and machining processes are complete.
The tube may have a sidewall and a first diameter, the sidewall being elastically radially expandable to a second diameter in response to an axial load, pressure due to centrifugation, an external vacuum, or internally-introduced pressure, the second diameter being sufficiently large to permit axial movement of the float in the tube during centrifugation.
The floats may move independently of each other. A consistent distance between floats may therefore not be maintained. Alternatively, the movement of the floats may dependent on each other, thereby maintaining a consistent difference. The consistent distance and/or trapping a target analyte or suspension material between the floats may occur mechanically—including, but not limited to, a shaft to link the floats and maintain distance—or magnetically—including magnets within the top and bottom end caps to repel or attract each other as desired.
The suspension, which is suspected of including the first target analyte and the second target analyte, is introduced into the tube 102. The first target analyte may be a lysed or fragmented portion of the second target analyte; or the first target analyte may be a different structure or composition than the second target analyte. When the first target analyte is a lysed or fragmented portion of the second target analyte, a solution containing a fluorescent marker may be used to label both the first and second target analytes. When the first and second target analytes are different or when the first target analyte is a lysed or fragmented portion of the second target analyte, a first solution containing a first fluorescent marker may be added to the tube 102 to label the first target analyte with the first fluorescent marker to provide a fluorescent signal for identification and characterization. A second solution containing a second fluorescent marker may be added to the tube 102 to label the second target analyte with the second fluorescent marker to provide a fluorescent signal for identification and characterization. The first and second target analytes of the suspension 106 may also be labeled prior to introduction into the tube 102. When the first and second target analytes have not been labeled prior to introduction to the tube 102, the contents of the tube 102 are mixed by shaking, swirling, rocking, inversion, rotating, vortex mixing, or stirring. The mixing may be done manually or with the aid of a machine, instrument, or the like. After mixing and conjugating, the first float 104 and the second float 114 are added to the tube 102. The system 100 is then centrifuged, thereby permitting separation of the suspension components into layers along an axial position in the tube 102 based on density. The first and second floats 104 and 114 are captured within the tube 102 at the same axial position as that of the first and second target analytes since the densities of the first and second floats 104 and 114 and first and second target analytes, respectively, are approximately the same. The first and second target analytes are trapped within an analysis area between the first and second floats 104 and 114 and the tube 102. The analysis area may then be imaged.
The first float 700 may also be used for quality control purposes or to trap a first target analyte located in the fraction 802. The second float 114 may be used to trap a second target analyte located in fraction 804. The first float 700, however, may be used to trap the first target analyte, such as lysed or fragmented pieces of the second target analyte or a different type of analyte, to test and determine whether the second target analyte is damaged. When the first target analyte is damaged, then it is highly likely that the second target analyte, after being trapped, may be damaged as well. Various properties or characteristics of the first target analyte may be altered when the second target analyte has been damaged. These alterations may have a significant effect on subsequent analysis or processing. When the first target analyte is undamaged, then it is likely that the second target analyte will be undamaged as well.
The target analytes 1010 and 1018 may have a number of different types of surface protein molecules located on the surface. Each type of surface protein is a molecule, such an antigen, capable of attaching a particular ligand, such as an antibody. As a result, ligands can be used to classify the target particles and determine the specific type of target particles present in the suspension by conjugating ligands that attach to particular surface proteins with a particular fluorescent probe. For example, each type of fluorescent probe emits light in a narrow wavelength range of the electromagnetic spectrum called a “channel” when an appropriate stimulus, such as light with a shorter wavelength, is applied. A first type of fluorescent probe that emits light in the red channel can be attached to a first ligand that binds specifically to a first type of surface protein of a first target analyte; a second type of fluorescent probe that emits light in the blue channel can be attached to a second ligand that binds specifically to a second type of surface protein of a second target analyte. The channel color observed as a result of stimulating the target material identifies the type of surface protein, and because surface proteins can be unique to particular target particles, the channel color can also be used to identify the target particle. Examples of suitable fluorescent probes include, but are not limited to, commercially available dyes, such as quantum dots, fluorescein, FITC (“fluorescein isothiocyanate”), R-phycoerythrin (“PE”), Texas Red, allophycocyanin, Cy5, Cy7, cascade blue, DAPI (“4′,6-diamidino-2-phenylindole”) and TRITC (“tetramethylrhodamine isothiocyanate”), and combinations of dyes, such as CY5PE, CY7APC, and CY7PE.
The ligands may include a primary antibody that bind to biomarkers, the biomarkers include, but are not limited to, EpCAM, AMACR, Androgen receptor, CD146, CD227, CD235, CD24, CD30, CD44, CD45, CD56, CD81, CD105, CD324, CD325, MUC1, CEA, cMET, EGFR, Folate receptor, HER2, Mammaglobin, PSMA, or combinations thereof.
It should be noted that the target analyte need not be in one single focal plane between the tube and magnetizable float to be properly imaged. The target analyte may appear at any depth and at any focal plane between the tube and the magnetizable float.
It should be further noted that multiple floats, not being limited in number, may be used to separate any number of target analytes from a suspension and/or create a suspension-air-float interface. When, for example, a suspension has three different target analytes, it may be desirous to use three floats (all three of which can come into axial alignment with three different target analytes) or to use four floats (three of which can come into axial alignment with three different target analytes and the fourth to create an interface with the air and suspension); it may be desirous to use four or five floats with a suspension having four different target analytes; and so on.
The target analytes may be fixed, permeabilized, and labeled. The system is then analyzed to determine the location and characterization of at least one specific target analyte. The target analytes may then be isolated and analyzed using any appropriate analysis method or technique, though more specifically extracellular analysis and/or intracellular analysis including intracellular protein labeling, in situ hybridization (“ISH”—a tool for analyzing DNA and/or RNA, such as gene copy number changes), or branched DNA (“bDNA”—a tool for analyzing DNA and/or RNA, such as mRNA expression levels) analysis. These techniques require fixation, permeabilization, and isolation of the target analyte prior to analysis. Some of the intracellular proteins which may be labeled include, but are not limited to, cytokeratin (“CK”), actin, Arp2/3, coronin, dystrophin, FtsZ, myosin, spectrin, tubulin, collagen, cathepsin D, ALDH, PBGD, Akt1, Akt2, c-myc, caspases, survivin, p27kip, FOXC2, BRAF, Phospho-Akt1 and 2, Phospho-Erk1/2, Erk1/2, P38 MAPK, Vimentin, ER, PgR, PI3K, pFAK, KRAS, ALKH1, Twist/, Snail1, ZEB1, Slug, Ki-67, M30, MAGEA3, phosphorylated receptor kinases, modified histories, chromatin-associated proteins, and MAGE. To fix, permeabilize, or label, fixing agents (such as formaldehyde, formalin, methanol, acetone, paraformaldehyde, or glutaraldehyde), detergents (such as saponin, polyoxyethylene, digitonin, octyl (3-glucoside, octyl β-thioglucoside, 1-S-octyl-β-D-thioglucopyranoside, polysorbate-20, CHAPS, CHAPSO, (1,1,3,3-Tetramethylbutyl)phenyl-polyethylene glycol or octylphenol ethylene oxide), or labeling agents (such as fluorescently-labeled antibodies, Pap stain, Giemsa stain, or hematoxylin and eosin stain) may be used.
The foregoing description, for purposes of explanation, used specific nomenclature to provide a thorough understanding of the disclosure. However, it will be apparent to one skilled in the art that the specific details are not required in order to practice the systems and methods described herein. The foregoing descriptions of specific embodiments are presented by way of examples for purposes of illustration and description. They are not intended to be exhaustive of or to limit this disclosure to the precise forms described. Many modifications and variations are possible in view of the above teachings. The embodiments are shown and described in order to best explain the principles of this disclosure and practical applications, to thereby enable others skilled in the art to best utilize this disclosure and various embodiments with various modifications as are suited to the particular use contemplated. It is intended that the scope of this disclosure be defined by the following claims and their equivalents:
This application claims the benefit of Provisional Application No. 61/625,863; filed Apr. 18, 2012 which is incorporated by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
61625863 | Apr 2012 | US |